Development and characterization of synthetic antibodies binding to the cystic fibrosis conductance regulator

No abstract is available for this paper.

• Publication year

  2016

• Venue

  mAbs

• Publication date

  2016-05-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/19420862.2016.1186320PMID 27185291PMCID PMC4968092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional inhibition of β-catenin-mediatedWnt signaling by intracellular VHHantibodies

  2014cited by this paper
• Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC exporter

  2014cited by this paper
• Synthetic antibody technologies.

  2014cited by this paper
• Regulatory R region of the CFTR chloride channel is a dynamic integrator of phospho-dependent intra- and intermolecular interactions

  2013cited by this paper
• CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.

  2013cited by this paper
• Fabs enable single particle cryoEM studies of small proteins.

  2012cited by this paper
• Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane

  2010cited by this paper
• NMR evidence for differential phosphorylation‐dependent interactions in WT and ΔF508 CFTR

  2010cited by this paper
• Crystal structure of full-length KcsA in its closed conformation

  2009cited by this paper
• Architecture of the cystic fibrosis transmembrane conductance regulator protein and structural changes associated with phosphorylation and nucleotide binding.

  2009cited by this paper
• Phenylalanine-508 mediates a cytoplasmic–membrane domain contact in the CFTR 3D structure crucial to assembly and channel function

  2008cited by this paper
• Computational studies reveal phosphorylation-dependent changes in the unstructured R domain of CFTR.

  2008cited by this paper
• A dominant conformational role for amino acid diversity in minimalist protein-protein interfaces.

  2008cited by this paper
• Synthetic antibodies for specific recognition and crystallization of structured RNA

  2008cited by this paper
• Submitting antibodies to binding arbitration.

  2008cited by this paper
• CFTR function and prospects for therapy.

  2008cited by this paper
• High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.

  2007cited by this paper
• CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices

  2007cited by this paper
• Identifying specificity profiles for peptide recognition modules from phage-displayed peptide libraries

  2007cited by this paper
• Domain interdependence in the biosynthetic assembly of CFTR.

  2007cited by this paper
• F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive.

  2006cited by this paper
• Impact of the ΔF508 Mutation in First Nucleotide-binding Domain of Human Cystic Fibrosis Transmembrane Conductance Regulator on Domain Folding and Structure*

  2005cited by this paper
• Methods for the construction of phage-displayed libraries

  2005cited by this paper
• Side chain and backbone contributions of Phe508 to CFTR folding

  2005cited by this paper
• Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia.

  2005cited by this paper
• The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon.

  2004cited by this paper
• Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody.

  2004cited by this paper
• Structure of nucleotide‐binding domain 1 of the cystic fibrosis transmembrane conductance regulator

  2004cited by this paper
• IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains.

  2003cited by this paper
• Conformational and Temperature-sensitive Stability Defects of the ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator in Post-endoplasmic Reticulum Compartments*

  2001cited by this paper
• A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution.

  2000cited by this paper
• Biosynthesis and degradation of CFTR.

  1999cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel.

  1991cited by this paper
• Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance.

  1991cited by this paper
• CFTR: development of high- affinity antibodies and localization in sweat gland.

  1991cited by this paper
• Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

  1989cited by this paper
• Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA

  1989cited by this paper
• A Dominant Conformational Role for Amino Acid Diversity in Minimalist Protein-protein Interfaces Nih Public Access Introduction

  year unknowncited by this paper

• Recent Strategic Advances in CFTR Drug Discovery: An Overview

  2020cites this paper
• Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue

  2019cites this paper
• A synthetic anti-Frizzled antibody engineered for broadened specificity exhibits enhanced anti-tumor properties

  2018cites this paper